179 related articles for article (PubMed ID: 18941250)
21. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
22. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells.
Yamamoto K; Kawamura I; Tominaga T; Nomura T; Kohda C; Ito J; Mitsuyama M
Clin Exp Immunol; 2005 Nov; 142(2):268-74. PubMed ID: 16232213
[TBL] [Abstract][Full Text] [Related]
23. Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.
Fallarino F; Grohmann U; Bianchi R; Vacca C; Fioretti MC; Puccetti P
J Immunol; 2000 Nov; 165(10):5495-501. PubMed ID: 11067902
[TBL] [Abstract][Full Text] [Related]
24. Novel diversity in Th1, Th2 type differentiation of hemagglutinin-specific T cell clones elicited by natural influenza virus infection in three major haplotypes (H-2b,d,k).
Graham CM; Smith CA; Thomas DB
J Immunol; 1998 Aug; 161(3):1094-103. PubMed ID: 9686567
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.
Bellone G; Turletti A; Artusio E; Mareschi K; Carbone A; Tibaudi D; Robecchi A; Emanuelli G; Rodeck U
Am J Pathol; 1999 Aug; 155(2):537-47. PubMed ID: 10433946
[TBL] [Abstract][Full Text] [Related]
26. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
28. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
29. Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.
Steigerwald-Mullen P; Kurilla MG; Braciale TJ
J Virol; 2000 Aug; 74(15):6748-59. PubMed ID: 10888613
[TBL] [Abstract][Full Text] [Related]
30. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
[TBL] [Abstract][Full Text] [Related]
31. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.
Schepers K; Toebes M; Sotthewes G; Vyth-Dreese FA; Dellemijn TA; Melief CJ; Ossendorp F; Schumacher TN
J Immunol; 2002 Sep; 169(6):3191-9. PubMed ID: 12218137
[TBL] [Abstract][Full Text] [Related]
32. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
[TBL] [Abstract][Full Text] [Related]
33. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
35. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
36. The role of IFN in respiratory syncytial virus pathogenesis.
Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
[TBL] [Abstract][Full Text] [Related]
37. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
[TBL] [Abstract][Full Text] [Related]
38. Immunoregulation in pancreatic cancer patients.
Plate JM; Shott S; Harris JE
Cancer Immunol Immunother; 1999 Aug; 48(5):270-9. PubMed ID: 10478644
[TBL] [Abstract][Full Text] [Related]
39. Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans.
Ma Y; Yuan B; Zhuang R; Zhang Y; Liu B; Zhang C; Zhang Y; Yu H; Yi J; Yang A; Jin B
PLoS Pathog; 2015 Apr; 11(4):e1004788. PubMed ID: 25836633
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone modulates T-cell response after major abdominal surgery.
Pratschke S; von Dossow-Hanfstingl V; Dietz J; Schneider CP; Tufman A; Albertsmeier M; Winter H; Angele MK
J Surg Res; 2014 Jun; 189(1):117-25. PubMed ID: 24650456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]